Literature DB >> 16952023

Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement by Bartlett et al.

Ravi S Chari, W Scott Helton, Robert D Marsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952023     DOI: 10.1245/s10434-006-9025-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.

Authors:  Xiaofeng Sun; Yan Wu; Wenda Gao; Keiichi Enjyoji; Eva Csizmadia; Christa E Müller; Takashi Murakami; Simon C Robson
Journal:  Gastroenterology       Date:  2010-06-25       Impact factor: 22.682

Review 2.  Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.

Authors:  Tobias Engel Ayer Botrel; Luciana Gontijo de Oliveira Clark; Luciano Paladini; Otávio Augusto C Clark
Journal:  BMC Cancer       Date:  2016-08-24       Impact factor: 4.430

3.  Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.

Authors:  Stefano Bacchetti; Enricomaria Pasqual; Elena Crozzolo; Alessandra Pellarin; Pier Paolo Cagol
Journal:  Med Devices (Auckl)       Date:  2009-03-16

4.  Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis.

Authors:  Georgi Atanasov; Karoline Dino; Katrin Schierle; Corinna Dietel; Gabriela Aust; Johann Pratschke; Daniel Seehofer; Moritz Schmelzle; Hans-Michael Hau
Journal:  World J Surg Oncol       Date:  2019-12-12       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.